[Skip to Content]
[Skip to Content Landing]

July 2019 - April 2016

Decade

Year

Issue

June 2019, Vol 4, No. 6, Pages 503-601

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2019;4(6):503. doi:10.1001/jamacardio.2018.3200
Original Investigation

Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial

Abstract Full Text
has audio
JAMA Cardiol. 2019;4(6):515-523. doi:10.1001/jamacardio.2019.1049

This post hoc analysis of the COMMANDER HF randomized clinical trial examines whether low-dose rivaroxaban was associated with a reduction in thromboembolic events.

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2019;4(6):526-548. doi:10.1001/jamacardio.2018.4729

This cohort study assesses treatment strategies and 1-year clinical outcomes of antithrombotic and CHF therapies for patients with newly diagnosed AF with concomitant congestive heart failure.

Association of Time Between Left Ventricular and Aortic Systolic Pressure Peaks With Severity of Aortic Stenosis and Calcification of Aortic Valve

Abstract Full Text
free access
JAMA Cardiol. 2019;4(6):549-555. doi:10.1001/jamacardio.2019.1180

This cohort study investigates the association of time between left ventricular and aortic systolic pressure peaks in adults with severe aortic stenosis.

Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis

Abstract Full Text
open access
JAMA Cardiol. 2019;4(6):556-563. doi:10.1001/jamacardio.2019.1384

This matched cohort study of US Medicare recipients assesses the association between ambulatory hemodynamic monitoring via a pulmonary artery pressure sensor and rates of heart failure hospitalization at 12 months after implant.

Brief Report

Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project

Abstract Full Text
JAMA Cardiol. 2019;4(6):564-568. doi:10.1001/jamacardio.2019.0388

This analysis examines the patterns of uptake of bioresorbable vascular scaffolds within the United States following device approval and changes in response to subsequent releases of data and US Food and Drug Administration warnings.

Association Between Physiological Stenosis Severity and Angina-Limited Exercise Time in Patients With Stable Coronary Artery Disease

Abstract Full Text
JAMA Cardiol. 2019;4(6):569-574. doi:10.1001/jamacardio.2019.1139

This cohort study assesses the association between all commonly-used indices of physiological stenosis severity and angina-limited exercise time in patients with stable angina.

Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis

Abstract Full Text
JAMA Cardiol. 2019;4(6):575-579. doi:10.1001/jamacardio.2019.1041

This mendelian randomization analysis estimates the required Lp(a)-lowering effect size that might translate into a reduction of coronary heart disease outcomes compared with the effect size of low-density lipoprotein cholesterol–lowering therapies.

Research Letter

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria

Abstract Full Text
open access
JAMA Cardiol. 2019;4(6):596-599. doi:10.1001/jamacardio.2019.1189

This study uses in vitro assays and a mouse model to investigate antibacterial properties of ticagrelor to follow up findings from 2 clinical trials that showed patients taking ticagrelor for cardiovascular disease had a lower risk of infection-related death and improved lung function compared with patients treated with clopidogrel.

Viewpoint

Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting: A Surgical Perspective

Abstract Full Text
JAMA Cardiol. 2019;4(6):505-506. doi:10.1001/jamacardio.2019.1046

This Viewpoint summarizes results and possible future directions of trials comparing percutaneous coronary intervention and coronary artery bypass grafting.

Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: Toward Patient-Centric Decision Making

Abstract Full Text
JAMA Cardiol. 2019;4(6):507-508. doi:10.1001/jamacardio.2019.1073

This Viewpoint discusses the relative outcomes of percutaneous coronary intervention and coronary artery bypass grafting, specifically with regards to patient-centered decision making.

From the Heart

A Christmas Story

Abstract Full Text
JAMA Cardiol. 2019;4(6):509-510. doi:10.1001/jamacardio.2019.1114

This essay describes a physician’s experience treating a young woman with myocardial infarction.

Editorial

A “New” Parameter for Aortic Stenosis Severity: What Goes Around Comes Around

Abstract Full Text
JAMA Cardiol. 2019;4(6):511-512. doi:10.1001/jamacardio.2019.1344

Using Genetics to Plan Future Randomized Trials of Lipoprotein(a) Lowering—How Much Reduction, for How Long, and in Whom?

Abstract Full Text
JAMA Cardiol. 2019;4(6):513-514. doi:10.1001/jamacardio.2019.1107
Invited Commentary

Antithrombotic Therapy in Heart Failure—The Clot Thickens

Abstract Full Text
has audio
JAMA Cardiol. 2019;4(6):524-525. doi:10.1001/jamacardio.2019.1108
Review

The Diagnostic and Prognostic Value of Echocardiographic Strain

Abstract Full Text
has active quiz
JAMA Cardiol. 2019;4(6):580-588. doi:10.1001/jamacardio.2019.1152

This narrative review discusses the characteristic patterns of myocardial deformation or strain by speckle-tracking echocardiography found in patients with various forms of cardiac dysfunction and discusses prognostic implications.

JAMA Cardiology Clinical Challenge

New-Onset Heart Failure

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2019;4(6):592-593. doi:10.1001/jamacardio.2019.0187

An adult with a history of alcohol abuse presented with progressive shortness of breath, lower extremity edema, and tachycardia. What would you do next?

JAMA Cardiology Clinical Guidelines Synopsis

2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol–Secondary Prevention

Abstract Full Text
JAMA Cardiol. 2019;4(6):589-591. doi:10.1001/jamacardio.2019.0911

This Clinical Guidelines Synopsis summarizes the 2018 American Heart Association/American College of Cardiology guidelines (secondary prevention) on management of blood cholesterol in patients at risk for atherosclerotic cardiovascular disease.

Cardiovascular Images

A Woman in Her Early 70s With Altered Mental Status and Left-Sided Weakness

Abstract Full Text
has multimedia
JAMA Cardiol. 2019;4(6):594. doi:10.1001/jamacardio.2019.0758

A woman in her early 70s presented with altered mental status and decreased power in her left extremities.

Comment & Response

We Can Learn From the Past, but We Must Pave the Future of Congenital Heart Disease Research

Abstract Full Text
JAMA Cardiol. 2019;4(6):599-600. doi:10.1001/jamacardio.2019.1066

We Can Learn From the Past, but We Must Pave the Future of Congenital Heart Disease Research—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(6):600. doi:10.1001/jamacardio.2019.1076

Interindividual and Intraindividual Responses to PCSK9 Inhibition

Abstract Full Text
JAMA Cardiol. 2019;4(6):600. doi:10.1001/jamacardio.2019.1194

Interindividual and Intraindividual Responses to PCSK9 Inhibition—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(6):600-601. doi:10.1001/jamacardio.2019.1200
Correction

Error in Key Points, Abstract, and Methods sections and Title

Abstract Full Text
free access
JAMA Cardiol. 2019;4(6):601. doi:10.1001/jamacardio.2019.2121
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2019;4(6):504. doi:10.1001/jamacardio.2018.3201
×